3MB-PP1

CAS No. 956025-83-5

3MB-PP1 ( —— )

Catalog No. M27450 CAS No. 956025-83-5

3MB-PP1 is an inhibitor of Polo-like kinase 1 (PLK1) and inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK) with an IC50 of 2 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 Get Quote
10MG 132 Get Quote
25MG 267 Get Quote
50MG 425 Get Quote
100MG 624 Get Quote
500MG 1314 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3MB-PP1
  • Note
    Research use only, not for human use.
  • Brief Description
    3MB-PP1 is an inhibitor of Polo-like kinase 1 (PLK1) and inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK) with an IC50 of 2 μM.
  • Description
    3MB-PP1 is an inhibitor of Polo-like kinase 1 (PLK1) and inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK) with an IC50 of 2 μM. 3MB-PP1 can be used in studies about cell division and hypha formation of Candida albicans.(In Vitro):In a strain bearing analog-sensitive alleles of SSN3(Cdk8), 3MB-PP1 (5 μM) stimulates hyphal growth.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PLK
  • Recptor
    BTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    956025-83-5
  • Formula Weight
    295.4
  • Molecular Formula
    C17H21N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=1C=NC2=C(C1N)C(=NN2C(C)(C)C)CC=3C=CC=C(C3)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Somana Siva Prasad, et al. A QUALITY BY DESIGN APPROACH FOR DEVELOPMENT OF SIMPLE AND ROBUST REVERSED PHASE STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF IBRUTINIB AND ITS IMPURITIES.
molnova catalog
related products
  • Epimedin A

    Epimedin A has anti-osteoporosis activities in vivo.

  • GW843682X

    GW843682X is a selective, ATP-competitive inhibitor of PLK1 and PLK3, with IC50s of 2.2 nM and 9.1 nM, respectively, and is also >100-fold selective against ~30 other kinases.

  • Rigosertib

    Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM.